Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Autoimmune and genetic diseases

16.07.2004



Autoimmune diseases are quite complex and this is due to the fact that these illnesses do not depend on just one gene. Thus, in order to find a suitable treatment, it is not enough to identify a gene involved in the development of the disease – each and every one has to be identified. To this end, a number of strategies have been design; for example, many geneticists have begun to analyse the genetic differences between healthy individuals and ill ones. A team at the Leioa campus of the University of the Basque Country are using this very strategy in the study of lupus - an autoimmune disease.

Differences in the markers

All of us are genetically very similar, almost the same, in fact. If two people are chosen at random, 99.9% of their genome is identical. Even so, we observe that these two persons have differences, for example, physical aspect or susceptibility to certain illnesses. Some of these differences are found in the genome markers.



The markers (single nucleotide polymorphism or SNP) are usually located at concrete points along the genome and contain information about the genes in close proximity to these. If the genome were a highway, the markers would be milestones; the genome has thousands of them.

Each one of these SNP may be represented by a letter corresponding to the marker nucleotide. There are four nucleotides in the DNA: adenine, cytosine, guanine and thymine. A number of studies have already identified the relation between certain markers ad a number of diseases. Moreover, the markers provide a way of analysing the genome as a whole and, thereby, in the case of autoimmune illnesses, all the genes involved can be found.

In this analysis, the differences between the markers of healthy and ill people are studied. If, in a marker, adenine is normally present in both healthy and ill individuals, then it is clear that there is no difference here and this marker is not one that defines the illness. On the other hand, if thymine appears instead of adenine in the sick individuals, this marker may be related to the disease. Once these markers have been identified, the search for those genes involved begins close to these markers.

But, in order to analyse the differences between the markers, these have to be first identified. This is the work being undertaken at the Leioa campus.

Identification of markers

In order to identify the markers of an individual person, a sample of their blood is required. From this sample the individual’s DNA is extracted in order to analyse the markers. There are a number of techniques available to this end but normally, depending on the nucleotide, it is visualised in one colour or another. So, depending on the colour, the nucleotide of each marker is identified.

These identifications have to be repeated until a data base of markers of healthy and ill persons is completed. Finally, with the help of computers, the markers which define the difference between both groups of individuals are established. But the work is not finished there. Given that these results still have a long road to travel to find the genes involved in the disease and to find treatment for its cure.

Garazi Andonegi | Basque research
Further information:
http://www.elhuyar.com
http://www.ehu.es

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>